{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:26:29Z","timestamp":1792207589550,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11060-015-1805-2","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T15:35:45Z","timestamp":1431963345000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Venous thromboembolism (VTE) and glioblastoma"],"prefix":"10.1007","volume":"124","author":[{"given":"Shlomit","family":"Yust-Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Webre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar A.","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad S.","family":"Lhadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri S.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"1805_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","volume":"78","author":"N Levitan","year":"1999","unstructured":"Levitan N, Dowlati A, Remick SC et al (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using medicare claims data. Medicine (Baltimore) 78:285\u2013291","journal-title":"Medicine (Baltimore)"},{"key":"1805_CR2","unstructured":"Anderson F, Huang W, Sullivan C, et al (2001) The continuing risk of venous thromboembolism following operation for glioma: findings from the Glioma Outcomes Project. Thromb Hemost, 86(Suppl):OC902"},{"key":"1805_CR3","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0959-8049(97)00167-6","volume":"33","author":"AA Brandes","year":"1997","unstructured":"Brandes AA, Scelzi E, Salmistraro G et al (1997) Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study. Eur J Cancer 33:1592\u20131596","journal-title":"Eur J Cancer"},{"key":"1805_CR4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E","volume":"89","author":"LC Marras","year":"2000","unstructured":"Marras LC, Geerts WH, Perry JR (2000) The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence based review. Cancer 89:640\u2013646","journal-title":"Cancer"},{"issue":"Suppl 4","key":"1805_CR5","doi-asserted-by":"crossref","first-page":"iv73","DOI":"10.1093\/neuonc\/nos197","volume":"14","author":"JR Perry","year":"2012","unstructured":"Perry JR (2012) Thromboembolic disease in patients with high-grade glioma. Neuro Oncol 14(Suppl 4):iv73\u2013iv80","journal-title":"Neuro Oncol"},{"issue":"2","key":"1805_CR6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1179\/1743132812Y.0000000126","volume":"35","author":"KL Chaichana","year":"2013","unstructured":"Chaichana KL, Pendleton C, Jackson C, Quinones-Hinojosa A (2013) Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res 35(2):206\u2013211","journal-title":"Neurol Res"},{"issue":"Suppl 1","key":"1805_CR7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0049-3848(12)70009-9","volume":"129","author":"AA Khorana","year":"2012","unstructured":"Khorana AA (2012) Risk assessment for cancer-associated thrombosis: what is the best approach? Thromb Res 129(Suppl 1):S10\u2013S15. doi: 10.1016\/S0049-3848(12)70009-9","journal-title":"Thromb Res"},{"issue":"29","key":"1805_CR8","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","volume":"27","author":"AA Khorana","year":"2009","unstructured":"Khorana AA, Connolly GC (2009) Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 27(29):4839\u20134847","journal-title":"J Clin Oncol"},{"issue":"10","key":"1805_CR9","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10):4902\u20134907. doi: 10.1182\/blood-2007-10-116327 Epub 2008 Jan 23","journal-title":"Blood"},{"issue":"282","key":"1805_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53(282):457\u2013481","journal-title":"J Am Stat Assoc"},{"issue":"9","key":"1805_CR11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","volume":"167","author":"C Huerta","year":"2007","unstructured":"Huerta C, Johansson S, Wallander MA, Garc\u0131\u00b4a Rodr\u0131\u00b4guez LA (2007) Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 167(9):935\u2013943","journal-title":"Arch Intern Med"},{"issue":"9","key":"1805_CR12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","volume":"173","author":"SA Johannesdottir","year":"2013","unstructured":"Johannesdottir SA, Horv\u00e1th-Puh\u00f3 E, Dekkers OM et al (2013) Use of glucocorticoids and risk of venous thromboembolisma nationwide population-based case-control study. JAMA Intern Med 173(9):743\u2013752","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1805_CR13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11739-007-0026-X","volume":"2","author":"A Squizzato","year":"2007","unstructured":"Squizzato A, Gerdes VE, Ageno W, Bu\u00a8ller HR (2007) The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med 2(2):76\u201383","journal-title":"Intern Emerg Med"},{"issue":"11","key":"1805_CR14","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/j.1538-7836.2010.04034.x","volume":"8","author":"B Zaane van","year":"2010","unstructured":"van Zaane B, Nur E, Squizzato A et al (2010) Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost 8(11):2483\u20132493","journal-title":"J Thromb Haemost"},{"key":"1805_CR15","doi-asserted-by":"crossref","unstructured":"Thaler J, Ay C, Kaider A, et al. (2014) Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas. Neuro Oncol, nou106 (PubMed PMID: 24987133)","DOI":"10.1093\/neuonc\/nou106"},{"issue":"2","key":"1805_CR16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.thromres.2012.09.020","volume":"131","author":"J Thaler","year":"2013","unstructured":"Thaler J, Preusser M, Ay C, Kaider A et al (2013) Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients. Thromb Res 131(2):162\u2013165","journal-title":"Thromb Res"},{"key":"1805_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1538-7836.2009.03690.x","volume":"8","author":"EO Jenkins","year":"2010","unstructured":"Jenkins EO, Schiff D, Mackman N, Key NS (2010) Venous thromboembolism in malignant gliomas. J Thromb Hemost 8:221\u2013227","journal-title":"J Thromb Hemost"},{"key":"1805_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0037-1613190","volume":"88","author":"IC Weitz","year":"2002","unstructured":"Weitz IC, Israel VK, Waisman JR, Presant CA, Rochanda L, Liebman HA (2002) Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation. Thromb Haemost 88:213\u2013220","journal-title":"Thromb Haemost"},{"key":"1805_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2141.2003.03971.x","volume":"120","author":"N Paredes","year":"2003","unstructured":"Paredes N, Xu L, Berry LR, Chan AK (2003) The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces. Br J Haematol 120:315\u2013324","journal-title":"Br J Haematol"},{"key":"1805_CR20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2141.1992.tb02978.x","volume":"81","author":"J Walsh","year":"1992","unstructured":"Walsh J, Wheeler HR, Geczy CL (1992) Modulation of tissue factor on human monocytes by cisplatin and adriamycin. Br J Haematol 81:480\u2013488","journal-title":"Br J Haematol"},{"key":"1805_CR21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1200\/JCO.1988.6.2.276","volume":"6","author":"JS Rogers II","year":"1988","unstructured":"Rogers JS II, Murgo AJ, Fontana JA, Raich PC (1988) Chemotherapy for breast cancer decreases plasma protein C and protein S. J Clin Oncol 6:276\u2013281","journal-title":"J Clin Oncol"},{"key":"1805_CR22","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1158\/1535-7163.MCT-06-0154","volume":"5","author":"J Woodley-Cook","year":"2006","unstructured":"Woodley-Cook J, Shin LY, Swystun L, Caruso S, Beaudin S, Liaw PC (2006) Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway. Mol Cancer Ther 5:3303\u20133311","journal-title":"Mol Cancer Ther"},{"key":"1805_CR23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/oxfordjournals.annonc.a010723","volume":"7","author":"M Cwikiel","year":"1996","unstructured":"Cwikiel M, Eskilsson J, Albertsson M, Stavenow L (1996) The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture. Ann Oncol 7:731\u2013737","journal-title":"Ann Oncol"},{"key":"1805_CR24","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.ATV.0000030186.66672.36","volume":"22","author":"BC Kuenen","year":"2002","unstructured":"Kuenen BC, Levi M, Meijers JC et al (2002) Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor\/vascular endothelial growth factor receptor pathway in cancer patients. Arterioscler Thromb Vasc Biol 22:1500\u20131505","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1805_CR25","doi-asserted-by":"crossref","unstructured":"Thaler J, Ay C, Kaider A, Reitter EM, Haselb\u00f6ck J, Mannhalter C, Zielinski C, Marosi C, Pabinger I (2014) Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas. Neuro Oncol, nou106","DOI":"10.1093\/neuonc\/nou106"},{"issue":"9","key":"1805_CR26","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1538-7836.2010.03973.x","volume":"8","author":"JR Perry","year":"2010","unstructured":"Perry JR, Julian JA, Laperriere NJ et al (2010) PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost 8(9):1959\u20131965","journal-title":"J Thromb Haemost"},{"key":"1805_CR27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00280-007-0596-3","volume":"62","author":"HI Robins","year":"2008","unstructured":"Robins HI, O\u2019Neill A, Gilbert M et al (2008) Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial. Cancer Chemother Pharmacol 62:227\u2013233","journal-title":"Cancer Chemother Pharmacol"},{"key":"1805_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11060-009-9911-7","volume":"95","author":"SL Perry","year":"2009","unstructured":"Perry SL, Bohlin C, Reardon DA et al (2009) Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients. J Neurooncol 95:129\u2013134","journal-title":"J Neurooncol"},{"issue":"2","key":"1805_CR29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-013-1115-5","volume":"113","author":"A Salmaggi","year":"2013","unstructured":"Salmaggi A, Simonetti G, Trevisan E, Beecher D, Carapella CM, DiMeco F, Conti L, Pace A, Filippini G (2013) Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review. J Neurooncol 113(2):293\u2013303","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1805-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1805-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1805-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T11:53:22Z","timestamp":1652010802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1805-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1805-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}